Table 3.
This Study (n = 2068) |
Bowen et al. [28] (n = 928) |
Keogh et al. [13] (n = 105) 1 |
Zeitler et al. [12] | |||
---|---|---|---|---|---|---|
Edinburgh (n = 150) |
Glasgow (n = 133) |
|||||
n | % | % | % | % | % | |
Mental Health Conditions | ||||||
Depression | 940 | 45.5 | 11.6 | 49.5 | 55.3 | 33.1 |
Anxiety disorder | 557 | 26.9 | 36.2 | 64.7 | 15.0 | |
PTSD | 279 | 13.5 | 13.3 | 3.8 | ||
Schizophrenia | 218 | 10.5 | 13.3 | 7.5 3 | ||
Bipolar disorder | 143 | 6.9 | 5.7 | |||
EUPD | 104 | 5.0 | 14.7 2 | 6.8 2 | ||
AOD Use Disorders | ||||||
Amphetamine use disorder | 534 | 25.8 | ||||
Alcohol use disorder | 525 | 25.4 | 21.3 | 36.7 | 54.1 | |
Opiate use disorder | 359 | 17.4 | 53.3 4 | 46.6 4 | ||
Benzodiazepine use disorder | 330 | 16.0 | 34.0 | 22.6 | ||
Physical Health Conditions | ||||||
Chronic pain | 545 | 26.4 | 28.0 | 18.1 | ||
Chronic liver disease | 471 | 22.8 | 4.7 | 1.5 | ||
Hepatitis C | 434 | 21.0 | 6.3 | 23.1 | 24.8 | |
Low back pain | 322 | 15.6 | 17.1 | |||
Asthma | 265 | 12.8 | 4.2 | 20.9 | ||
Hypertension | 233 | 11.3 | 4.2 | 21.9 | ||
GORD | 204 | 9.9 | 26.7 | |||
Diabetes type II | 153 | 7.4 | 2.8 6 | 7.6 6 | ||
Osteoarthritis | 153 | 7.4 | 5.7 7 | |||
Dyslipidaemia | 142 | 6.9 | ||||
COPD | 123 | 5.9 | 2.9 | |||
Epilepsy | 121 | 5.9 | 7.6 | 6.0 | 3.0 | |
Brain injury | 82 | 4.0 | 3.3 5 | |||
Dermatitis/Eczema | 73 | 3.5 | 52.3 | 18.7 | 9.8 |
1 Self-reported condition prevalence rather than based on clinical records. 2 Personality disorder, not specifically EUPD. 3 Includes schizophrenia, non-organic psychosis, and bipolar disorder as reported by Queen et al. [16]. 4 Heroin dependence only. 5 Alcohol-related brain injury only. 6 Diabetes, not specifically type II. 7 Arthritis, not specifically osteoarthrosis.